514 related articles for article (PubMed ID: 16230723)
21. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections.
Tennenberg S; Lieser M; McCurdy B; Boomer G; Howington E; Newman C; Wolf I
Arch Surg; 1997 Dec; 132(12):1348-51. PubMed ID: 9403542
[TBL] [Abstract][Full Text] [Related]
22. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
23. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
[TBL] [Abstract][Full Text] [Related]
25. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
27. Are antiseptic-coated central venous catheters effective in a real-world setting?
Borschel DM; Chenoweth CE; Kaufman SR; Hyde KV; VanDerElzen KA; Raghunathan TE; Collins CD; Saint S
Am J Infect Control; 2006 Aug; 34(6):388-93. PubMed ID: 16877109
[TBL] [Abstract][Full Text] [Related]
28. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.
Ostendorf T; Meinhold A; Harter C; Salwender H; Egerer G; Geiss HK; Ho AD; Goldschmidt H
Support Care Cancer; 2005 Dec; 13(12):993-1000. PubMed ID: 15834740
[TBL] [Abstract][Full Text] [Related]
29. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.
Ciresi DL; Albrecht RM; Volkers PA; Scholten DJ
Am Surg; 1996 Aug; 62(8):641-6. PubMed ID: 8712561
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
Rosato AE; Tallent SM; Edmond MB; Bearman GM
Am J Infect Control; 2004 Dec; 32(8):486-8. PubMed ID: 15573055
[No Abstract] [Full Text] [Related]
31. Evaluation of an antiseptic triple-lumen catheter in an intensive care unit.
Hanley EM; Veeder A; Smith T; Drusano G; Currie E; Venezia RA
Crit Care Med; 2000 Feb; 28(2):366-70. PubMed ID: 10708168
[TBL] [Abstract][Full Text] [Related]
32. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
[TBL] [Abstract][Full Text] [Related]
33. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
[TBL] [Abstract][Full Text] [Related]
34. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients.
Vallés J; Fernández I; Alcaraz D; Chacón E; Cazorla A; Canals M; Mariscal D; Fontanals D; Morón A
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):847-53. PubMed ID: 18665819
[TBL] [Abstract][Full Text] [Related]
35. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults.
Lam TB; Omar MI; Fisher E; Gillies K; MacLennan S
Cochrane Database Syst Rev; 2014 Sep; (9):CD004013. PubMed ID: 25248140
[TBL] [Abstract][Full Text] [Related]
36. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
Walder B; Pittet D; Tramèr MR
Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
[TBL] [Abstract][Full Text] [Related]
37. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
38. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine.
Greenfeld JI; Sampath L; Popilskis SJ; Brunnert SR; Stylianos S; Modak S
Crit Care Med; 1995 May; 23(5):894-900. PubMed ID: 7736748
[TBL] [Abstract][Full Text] [Related]
39. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
[TBL] [Abstract][Full Text] [Related]
40. Decreasing catheter-related infection and hospital costs by continuous quality improvement.
Civetta JM; Hudson-Civetta J; Ball S
Crit Care Med; 1996 Oct; 24(10):1660-5. PubMed ID: 8874302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
